Sildenafil sublingual spray formulations
US10111833B2 · kind B2 · utility
0Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2017 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Apr 17, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to sublingual spray formulations containing sildenafil. The invention is further directed to methods of treating male sexual dysfunction or pulmonary arterial hypertension by administering sublingual spray formulations containing sildenafil to patients in need of such treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.